Edap Tms (NASDAQ:EDAP) Earns Hold Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Edap Tms (NASDAQ:EDAP) in a research note published on Monday. The firm issued a hold rating on the medical equipment provider’s stock.

EDAP has been the topic of several other research reports. HC Wainwright reiterated a “buy” rating and set a $19.00 price target on shares of Edap Tms in a report on Friday, March 28th. Jefferies Financial Group reaffirmed a “hold” rating and set a $2.00 target price (down from $8.00) on shares of Edap Tms in a research note on Friday, April 4th. Finally, Piper Sandler dropped their price target on shares of Edap Tms from $5.00 to $4.50 and set an “overweight” rating for the company in a research note on Friday, March 28th.

Edap Tms Price Performance

Edap Tms stock opened at $1.63 on Monday. The firm has a market capitalization of $60.48 million, a price-to-earnings ratio of -2.51 and a beta of 0.12. Edap Tms has a 52-week low of $1.26 and a 52-week high of $7.40. The company has a fifty day simple moving average of $2.08 and a 200-day simple moving average of $2.32. The company has a quick ratio of 1.46, a current ratio of 2.18 and a debt-to-equity ratio of 0.08.

Edap Tms (NASDAQ:EDAP) last released its earnings results on Thursday, March 27th. The medical equipment provider reported ($0.05) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.06. Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%. The business had revenue of $22.69 million for the quarter, compared to analyst estimates of $20.83 million. On average, equities analysts anticipate that Edap Tms will post -0.6 EPS for the current fiscal year.

Institutional Investors Weigh In On Edap Tms

Institutional investors and hedge funds have recently modified their holdings of the company. Illumine Investment Management LLC acquired a new position in Edap Tms in the 4th quarter valued at about $50,000. Jane Street Group LLC grew its holdings in shares of Edap Tms by 174.7% in the fourth quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider’s stock valued at $69,000 after purchasing an additional 73,361 shares in the last quarter. Millennium Management LLC increased its stake in Edap Tms by 218.5% during the 4th quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider’s stock worth $108,000 after buying an additional 33,558 shares during the period. BNP Paribas Financial Markets lifted its holdings in Edap Tms by 111.5% during the 4th quarter. BNP Paribas Financial Markets now owns 48,650 shares of the medical equipment provider’s stock worth $108,000 after buying an additional 25,650 shares in the last quarter. Finally, Schonfeld Strategic Advisors LLC boosted its position in Edap Tms by 48.5% in the 4th quarter. Schonfeld Strategic Advisors LLC now owns 160,800 shares of the medical equipment provider’s stock valued at $355,000 after buying an additional 52,500 shares during the period. Hedge funds and other institutional investors own 62.74% of the company’s stock.

About Edap Tms

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.